A-shares closed · 港股休市 Quotes 行情 · 28 Sep 20:16 CST
29 Sep 2026 · 03:15 CST Terminal Access 终端入口 →
605199.SH上海证券交易所 · 主板 Main

Huluwa ST葫芦娃

Traditional Chinese Medicine 中药Ⅱ
¥5.70−¥0.06 · −1.04%Delayed 行情延迟 · 28 Sep 2026 · 16:14 CST · CNY
Open 开盘
¥5.72
High 最高
¥5.78
Low 最低
¥5.68
Prev Close 昨收
¥5.76
Volume 成交量
79.5万股
Turnover 成交额
¥454.0万
Mkt Cap 总市值
¥23亿
P/E 市盈率
−5.7×
Recent Activity 近期动态All Filings 全部公告 →

8 significant filings since 1 Jun 2026: 3 on regulatory action, 2 on regulatory inquiry and 1 on guarantee or financial assistance, and 2 other kinds. The latest, on 15 Aug 2026: 海南葫芦娃药业集团股份有限公司关于收到海南证监局警示函的整改报告. On 15 Jul 2026 the company said it expects net profit for the period ending 30 Jun 2026 to fall by 4,166.73% to 4,996.67% from the same period a year earlier.
自 1 Jun 2026 起有 8 份重大公告:regulatory action 3 份、regulatory inquiry 2 份、guarantee or financial assistance 1 份,另有 2 类。最新一份(15 Aug 2026):海南葫芦娃药业集团股份有限公司关于收到海南证监局警示函的整改报告。15 Jul 2026 公司预告截至 30 Jun 2026 的净利润较上年同期下降 4,166.73% 至 4,996.67%。

Price History 价格走势

1 session 个交易日, Mon 28 Sep 2026 · Live one-minute prices 实时分钟价格 · High 最高 ¥5.76 · Low 最低 ¥5.68 · −1.04% on the previous close of ¥5.76 较昨收
5.685.705.725.745.76
Volume 成交量
690
09:3010:3613:1214:1915:30

Against Its Own History 与自身历史比较

−5.7×
Median 中值 79.7× · Range 区间 66.4× to 505.3× · 10 periods 期
7.62×
Median 中值 6.47× · Range 区间 3.84× to 10.74× · 20 periods 期

Period by Period 逐期

Period 报告期Close at Period End 期末收盘TTM EPS 滚动每股收益 BPS 每股净资产
30 Jun 2026 中报¥5.19−¥1.01—¥0.756.94×
31 Mar 2026 一季报¥6.83−¥0.85—¥0.967.12×
31 Dec 2025 年报¥7.62−¥0.72—¥1.037.39×
30 Sep 2025 三季报¥8.83−¥0.43—¥1.725.13×
30 Jun 2025 中报¥9.07−¥0.78—¥1.765.16×
31 Mar 2025 一季报¥14.81−¥0.70—¥1.818.17×
31 Dec 2024 年报¥15.93−¥0.69—¥1.759.10×
30 Sep 2024 三季报¥13.93−¥0.45—¥2.146.50×
30 Jun 2024 中报¥9.75−¥0.02—¥2.543.84×
31 Mar 2024 一季报¥12.30——¥2.634.68×
31 Dec 2023 年报¥15.16¥0.03505.3×¥2.565.92×
30 Sep 2023 三季报¥14.87¥0.2266.4×¥2.735.45×
30 Jun 2023 中报¥15.14¥0.2267.6×¥2.695.63×
31 Mar 2023 一季报¥16.94¥0.2469.4×¥2.646.43×
31 Dec 2022 年报¥16.02¥0.2174.8×¥2.536.32×
30 Sep 2022 三季报¥14.39¥0.1784.6×¥2.505.76×
30 Jun 2022 中报¥17.65¥0.1992.9×¥2.467.16×
31 Mar 2022 一季报¥20.78¥0.19109.4×¥2.398.68×
31 Dec 2021 年报¥24.92¥0.18138.4×¥2.3210.74×
30 Sep 2021 三季报¥20.75¥0.3166.9×¥2.338.89×

Consensus Forward EPS 机构预测每股收益

No broker forecasts for this company yet 暂无机构预测

Not Computed 未计算
  • Dividend Yield 股息率
  • Free Cash Flow 自由现金流
  • EV/EBITDA